ReviewAsian journal of andrology2024

Navigating the evolving diagnostic and therapeutic landscape of low- and intermediate-risk prostate cancer.

Fabio Zattoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.